Teriflunomide Tablets (3d0a3975 6caf 45a7 90a3 19f0725d4697 01)
Teriflunomide Tablet, Film Coated
Product Images NDC 70710-1114
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Teriflunomide (NDC 70710-1114). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Teriflunomide Tablets (3d0a3975 6caf 45a7 90a3 19f0725d4697 02)
This is a clinical study evaluating the efficacy of different doses of teriflunomide, a drug used for treating relapsing-remitting multiple sclerosis (RRMS), compared to a placebo. The study lasted for 108 weeks and consisted of a total of 873 patients taking either a placebo or one of two doses of teriflunomide (7 mg or 14 mg). The number of patients at risk was recorded at different time points during the study, and statistical analysis showed that the 14 mg dose of teriflunomide was significantly better than the placebo for treating RRMS.*
Teriflunomide Tablets (3d0a3975 6caf 45a7 90a3 19f0725d4697 03)
This seems to be a table presenting disability progression data for three different treatments (Placebo, 7 mg Terifunomide and 14 mg Terilunomide). The data shows the percentage of sustained disability progression for 12 weeks for each treatment. There are also graphs displaying the number of patients at risk over the weeks, for each treatment. No further context or explanation is available.*
Teriflunomide Tablets (3d0a3975 6caf 45a7 90a3 19f0725d4697 04)
This is a description for Teriflunomide tablets, with a recommended usual dosage of one tablet taken orally once daily. The tablets contain 7 mg of Terifunomide. They can be taken with or without food and should be stored between 20°C-25°C. The package is child-resistant with a warning to keep out of reach of children. The medication guide is available at '2ydususa comimeaguides' or can be called at 1-877-9838775. The manufacturer is Zydus Lifesciences Ltd., located in Bhmesabad, and the distributor is Zydus Pharmaceuticals USA Inc., located in Penvingon.*
Teriflunomide Tablets (3d0a3975 6caf 45a7 90a3 19f0725d4697 05)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
